Although both cell lines are ER+luminal breast cancer cell lines, a key difference between them at the molecularlevel is that MCF7 cells express WT p53, whereas T47D cells carry aTP53 missense mutation (nonfunctional p53) (Schafer et al., 2000). Here, TP53 is linked to breast carcinoma.